These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2215925)

  • 1. The brain and the immune system: an intact immune system is essential for the manifestation of withdrawal in opiate addicted rats.
    Dougherty PM; Pellis NR; Dafny N
    Neuroscience; 1990; 36(2):285-9. PubMed ID: 2215925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune system and opiate withdrawal.
    Dafny N; Dougherty PM; Pellis NR
    Int J Immunopharmacol; 1989; 11(4):371-5. PubMed ID: 2674032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of lymphoid cells in the withdrawal syndrome of opiate dependent rats.
    Pellis NR; Kletzly NE; Dougherty PM; Aronowski J; Dafny N
    Life Sci; 1987 Apr; 40(16):1589-93. PubMed ID: 3550348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiation exposure modulates central opioid functions.
    Dougherty PM; Dafny N
    Exp Neurol; 1987 Nov; 98(2):301-16. PubMed ID: 3666080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enigmatic action of ciclosporine A on the naloxone-precipitated morphine withdrawal syndrome in mice.
    Berthold H; Borel JF; Flückiger E
    Neuroscience; 1989; 31(1):97-103. PubMed ID: 2771062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
    Caillé S; Espejo EF; Koob GF; Stinus L
    Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Sullivan ME; Hall SR; Milne B; Jhamandas K
    Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of neuro-immunologic interactions: cyclosporine modifies opiate withdrawal by effects on the brain and immune components.
    Dougherty PM; Aronowski J; Drath D; Dafny N
    J Neuroimmunol; 1987 Jan; 13(3):331-42. PubMed ID: 3793881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of an immune system to brain communication axis that affects central opioid functions: muramyl peptides attenuate opiate withdrawal.
    Dougherty PM; Drath DB; Dafny N
    Eur J Pharmacol; 1987 Sep; 141(2):253-60. PubMed ID: 2824218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
    Jones KL; Barr GA
    Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
    Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
    Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
    Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats.
    Cervo L; Romandini S; Samanin R
    Br J Pharmacol; 1983 Aug; 79(4):993-6. PubMed ID: 6686075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine alters opiate withdrawal in rodents.
    Dafny N; Wagle VG; Drath DB
    Life Sci; 1985 May; 36(18):1721-6. PubMed ID: 4039025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-cranial electrical stimulation attenuates the severity of naloxone-precipitated morphine withdrawal in rats.
    Dougherty PM; Dafny N
    Life Sci; 1989; 44(26):2051-6. PubMed ID: 2747416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimmune intercommunication, central opioids, and the immune response to bacterial endotoxin.
    Dougherty PM; Dafny N
    J Neurosci Res; 1988; 19(1):140-8. PubMed ID: 3343705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of opioid agonist-antagonist interaction on morphine dependence in rats.
    Suzuki T; Fukagawa Y; Yoshii T; Yanaura S
    Life Sci; 1988; 42(26):2729-37. PubMed ID: 3386409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacological modulation of opiate withdrawal using an up-/down-regulation of the noradrenergic system in opiate-dependent rats.
    Streel E; Dan B; Campanella S; Meyvaert A; Hanak C; Pelc I; Verbanck P
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):621-6. PubMed ID: 16146582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of morphine withdrawal signs in the rat after chronic treatment with naloxone.
    Suzuki T; Fukagawa Y; Misawa M
    Eur J Pharmacol; 1990 Mar; 178(2):239-42. PubMed ID: 2158457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
    Bell JA; Beglan CL
    Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.